US/UK/Canada

Share

Pick a time period -
Tags ( Active)

BIAL and Wanbang Announce Exclusive Licensing Agreement for Opicapone in China

Ongentys® (Opicapone) is a new treatment for Parkinson’s Disease approved by the European Commission in June 2016Porto, Portugal and Xuzhou, China, January 9th, 2018 - BIAL and Jiangsu Wanbang Biopharmaceutical Group Co., Ltd. (Wanbang), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma, SHA: 600196 and HKG: 02196) announced today that they have entered into an exclusive license agreement for the importation, packaging and commercialization of Opicapone in China (excluding Hong Kong, Macao and Taiwan). Under the terms of the agreement, BIAL will receive from

"ME AT MY BEST": People with Parkinson’s are much more than their disease

BIAL launches international campaign for World Parkinson's DayTo inspire and empower millions of people living with Parkinson’s around the world, Bial launches a touching campaign for the World Parkinson's Day showing that it is possible to live a normal life, and successfully perform everyday tasks. Imagine being unable to control your own body. In your mind, everything is exactly like it was; but your brain seems to have forgotten how to tell your body to do everyday tasks like tying up shoes or using a toothbrush. This is how it feels to live with Parkinson’s. A real

BIAL and Neurocrine Announce Exclusive North American Licensing Agreement for Opicapone

ONGENTYS®(opicapone) Approved in Europe in June 2016Porto, Portugal and San Diego, California, February 10, 2017 - BIAL and Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that they have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America. ONGENTYS® (opicapone) is a once-daily, peripherally-acting, highly-selective catechol-O-methyltransferase inhibitor (COMT inhibitor) that was approved in June 2016 by the European Commission as an adjunct therapy to preparations of levodopa/DOPA decarboxylase inhibitors for

There are no items matching the current filter
There are no more items matching the current filter
Back to top